Women experiencing menopause before age 40 face a substantially elevated cardiovascular burden that could reshape preventive care strategies for younger adults. This finding challenges the assumption that heart disease primarily affects older populations and suggests hormonal transitions deserve greater attention in cardiac risk assessment. Analysis of large-scale population data reveals that premature menopause correlates with a 40 percent increase in lifetime coronary heart disease risk compared to women with typical menopausal timing. The effect appears independent of traditional cardiovascular risk factors, pointing to estrogen's protective mechanisms as more critical than previously recognized. Women affected by early menopause represent roughly one percent of the population, yet their disproportionate cardiac vulnerability suggests targeted screening protocols may be warranted. The research reinforces emerging evidence that reproductive health events serve as windows into long-term disease susceptibility. From a clinical perspective, this represents confirmatory rather than revolutionary science, building on decades of research linking estrogen deficiency to cardiovascular decline. However, the quantified risk elevation provides actionable data for both patients and physicians. The findings support more aggressive lipid monitoring, earlier consideration of statin therapy, and lifestyle interventions for women with premature menopause. Limitations include the observational design, which cannot establish causation, and potential confounding from genetic factors that influence both menopausal timing and heart disease. Nevertheless, the magnitude of risk elevation warrants serious consideration in clinical guidelines, particularly as reproductive history often gets overlooked in standard cardiovascular assessments.